Structure

Physi-Chem Properties

Molecular Weight:  718.28
Volume:  690.635
LogP:  1.704
LogD:  1.213
LogS:  -4.215
# Rotatable Bonds:  9
TPSA:  224.81
# H-Bond Aceptor:  15
# H-Bond Donor:  5
# Rings:  6
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.197
Synthetic Accessibility Score:  6.178
Fsp3:  0.667
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.631
MDCK Permeability:  0.00010613949416438118
Pgp-inhibitor:  0.993
Pgp-substrate:  1.0
Human Intestinal Absorption (HIA):  0.897
20% Bioavailability (F20%):  0.947
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.136
Plasma Protein Binding (PPB):  44.58564376831055%
Volume Distribution (VD):  0.622
Pgp-substrate:  20.35983657836914%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.055
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.197
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.012
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.042
CYP3A4-inhibitor:  0.231
CYP3A4-substrate:  0.343

ADMET: Excretion

Clearance (CL):  1.445
Half-life (T1/2):  0.242

ADMET: Toxicity

hERG Blockers:  0.265
Human Hepatotoxicity (H-HT):  0.602
Drug-inuced Liver Injury (DILI):  0.363
AMES Toxicity:  0.046
Rat Oral Acute Toxicity:  0.248
Maximum Recommended Daily Dose:  0.293
Skin Sensitization:  0.261
Carcinogencity:  0.094
Eye Corrosion:  0.003
Eye Irritation:  0.007
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471493

Natural Product ID:  NPC471493
Common Name*:   CFXLQLVVACEBGI-VHMPTJLLSA-N
IUPAC Name:   n.a.
Synonyms:   7Beta-D-Xylosylbaccatin Iii
Standard InCHIKey:  CFXLQLVVACEBGI-VHMPTJLLSA-N
Standard InCHI:  InChI=1S/C36H46O15/c1-16-20(39)13-36(45)30(50-31(44)19-10-8-7-9-11-19)28-34(6,29(43)27(48-17(2)37)24(16)33(36,4)5)22(12-23-35(28,15-47-23)51-18(3)38)49-32-26(42)25(41)21(40)14-46-32/h7-11,20-23,25-28,30,32,39-42,45H,12-15H2,1-6H3/t20-,21+,22-,23+,25-,26+,27+,28-,30-,32+,34+,35-,36+/m0/s1
SMILES:  CC(=O)O[C@@H]1C2=C(C)[C@@H](O)C[C@@](C2(C)C)(O)[C@H]([C@H]2[C@@](C1=O)(C)[C@@H](O[C@H]1OC[C@H]([C@@H]([C@H]1O)O)O)C[C@@H]1[C@]2(CO1)OC(=O)C)OC(=O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL252932
PubChem CID:   44445497
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32766 luteibacter sp. Species Rhodanobacteraceae Bacteria n.a. n.a. n.a. PMID[18001087]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens IC50 < 10000.0 nM PMID[523521]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 < 10000.0 nM PMID[523521]
NPT547 Cell Line BGC-823 Homo sapiens IC50 < 10000.0 nM PMID[523521]
NPT81 Cell Line A549 Homo sapiens IC50 < 10000.0 nM PMID[523521]
NPT179 Cell Line A2780 Homo sapiens IC50 < 10000.0 nM PMID[523521]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471493 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9474 High Similarity NPC155329
0.9474 High Similarity NPC114357
0.9474 High Similarity NPC259144
0.9408 High Similarity NPC134685
0.9408 High Similarity NPC11588
0.9408 High Similarity NPC229545
0.9408 High Similarity NPC219419
0.9408 High Similarity NPC248265
0.9276 High Similarity NPC197037
0.9211 High Similarity NPC91730
0.9097 High Similarity NPC21410
0.9097 High Similarity NPC473670
0.9079 High Similarity NPC217918
0.9068 High Similarity NPC102465
0.9045 High Similarity NPC469399
0.9032 High Similarity NPC469477
0.9032 High Similarity NPC133430
0.8981 High Similarity NPC469417
0.8981 High Similarity NPC472393
0.8974 High Similarity NPC5115
0.8961 High Similarity NPC7095
0.8938 High Similarity NPC150893
0.8938 High Similarity NPC329960
0.8938 High Similarity NPC295408
0.8917 High Similarity NPC106895
0.8917 High Similarity NPC217091
0.8903 High Similarity NPC101043
0.8903 High Similarity NPC471103
0.8903 High Similarity NPC51602
0.8903 High Similarity NPC306799
0.8896 High Similarity NPC250046
0.8896 High Similarity NPC60509
0.8896 High Similarity NPC81698
0.8882 High Similarity NPC38696
0.8861 High Similarity NPC477735
0.8854 High Similarity NPC473632
0.8854 High Similarity NPC469730
0.8854 High Similarity NPC472549
0.8854 High Similarity NPC228204
0.8854 High Similarity NPC26033
0.8854 High Similarity NPC132599
0.8854 High Similarity NPC282239
0.8854 High Similarity NPC473611
0.8839 High Similarity NPC165260
0.8839 High Similarity NPC161239
0.8839 High Similarity NPC198455
0.8839 High Similarity NPC112216
0.8824 High Similarity NPC127857
0.8805 High Similarity NPC477736
0.879 High Similarity NPC472022
0.879 High Similarity NPC472005
0.879 High Similarity NPC256142
0.879 High Similarity NPC304876
0.879 High Similarity NPC237549
0.879 High Similarity NPC265395
0.879 High Similarity NPC257213
0.879 High Similarity NPC473414
0.879 High Similarity NPC472030
0.879 High Similarity NPC242262
0.879 High Similarity NPC1173
0.879 High Similarity NPC158333
0.879 High Similarity NPC249471
0.878 High Similarity NPC477469
0.878 High Similarity NPC477466
0.878 High Similarity NPC477473
0.878 High Similarity NPC477471
0.8766 High Similarity NPC477737
0.8765 High Similarity NPC471134
0.875 High Similarity NPC34012
0.8734 High Similarity NPC112523
0.8734 High Similarity NPC114410
0.8726 High Similarity NPC472548
0.8704 High Similarity NPC66193
0.8688 High Similarity NPC471102
0.8671 High Similarity NPC77719
0.8662 High Similarity NPC470153
0.8645 High Similarity NPC469513
0.8642 High Similarity NPC43304
0.8642 High Similarity NPC477188
0.8642 High Similarity NPC477190
0.8627 High Similarity NPC182869
0.8625 High Similarity NPC469771
0.8623 High Similarity NPC469421
0.8616 High Similarity NPC469422
0.8616 High Similarity NPC34066
0.8608 High Similarity NPC477905
0.8606 High Similarity NPC469420
0.8599 High Similarity NPC469448
0.8599 High Similarity NPC470245
0.8599 High Similarity NPC473214
0.8599 High Similarity NPC254558
0.8598 High Similarity NPC61891
0.8598 High Similarity NPC477491
0.8589 High Similarity NPC322420
0.8589 High Similarity NPC478073
0.8581 High Similarity NPC471107
0.8581 High Similarity NPC277053
0.8581 High Similarity NPC301946
0.8581 High Similarity NPC471100
0.858 High Similarity NPC476077
0.8562 High Similarity NPC11410
0.8554 High Similarity NPC469419
0.8544 High Similarity NPC329657
0.8544 High Similarity NPC469415
0.8539 High Similarity NPC472391
0.8537 High Similarity NPC477627
0.8535 High Similarity NPC476975
0.8535 High Similarity NPC473215
0.8526 High Similarity NPC474935
0.8519 High Similarity NPC477623
0.8516 High Similarity NPC80895
0.8516 High Similarity NPC471912
0.8506 High Similarity NPC472546
0.85 High Similarity NPC469456
0.85 High Similarity NPC469398
0.85 High Similarity NPC251139
0.8497 Intermediate Similarity NPC471623
0.8494 Intermediate Similarity NPC40138
0.8485 Intermediate Similarity NPC324769
0.8485 Intermediate Similarity NPC325732
0.8483 Intermediate Similarity NPC472392
0.8483 Intermediate Similarity NPC472375
0.8481 Intermediate Similarity NPC303429
0.8481 Intermediate Similarity NPC222102
0.8457 Intermediate Similarity NPC49297
0.8452 Intermediate Similarity NPC477894
0.8443 Intermediate Similarity NPC477488
0.8442 Intermediate Similarity NPC77493
0.8438 Intermediate Similarity NPC69425
0.8421 Intermediate Similarity NPC472372
0.8421 Intermediate Similarity NPC472374
0.8415 Intermediate Similarity NPC275477
0.8398 Intermediate Similarity NPC116862
0.8395 Intermediate Similarity NPC181924
0.8383 Intermediate Similarity NPC470735
0.8383 Intermediate Similarity NPC329647
0.8377 Intermediate Similarity NPC183270
0.8377 Intermediate Similarity NPC477904
0.8377 Intermediate Similarity NPC472547
0.8375 Intermediate Similarity NPC469647
0.8375 Intermediate Similarity NPC469648
0.8375 Intermediate Similarity NPC22571
0.8375 Intermediate Similarity NPC283875
0.8375 Intermediate Similarity NPC138641
0.8363 Intermediate Similarity NPC19056
0.8363 Intermediate Similarity NPC470583
0.8344 Intermediate Similarity NPC174982
0.8344 Intermediate Similarity NPC476973
0.8344 Intermediate Similarity NPC29704
0.8344 Intermediate Similarity NPC473088
0.8344 Intermediate Similarity NPC472572
0.8344 Intermediate Similarity NPC472575
0.8344 Intermediate Similarity NPC184817
0.8344 Intermediate Similarity NPC471104
0.8344 Intermediate Similarity NPC472568
0.8344 Intermediate Similarity NPC158663
0.8344 Intermediate Similarity NPC70403
0.8344 Intermediate Similarity NPC470159
0.8344 Intermediate Similarity NPC200471
0.8344 Intermediate Similarity NPC477467
0.8344 Intermediate Similarity NPC470157
0.8344 Intermediate Similarity NPC177940
0.8344 Intermediate Similarity NPC171525
0.8344 Intermediate Similarity NPC472571
0.8344 Intermediate Similarity NPC472556
0.8344 Intermediate Similarity NPC96903
0.8344 Intermediate Similarity NPC469349
0.8344 Intermediate Similarity NPC476784
0.8343 Intermediate Similarity NPC289383
0.8333 Intermediate Similarity NPC149002
0.8333 Intermediate Similarity NPC91703
0.8333 Intermediate Similarity NPC469458
0.8333 Intermediate Similarity NPC88176
0.8333 Intermediate Similarity NPC469459
0.8333 Intermediate Similarity NPC469396
0.8323 Intermediate Similarity NPC472576
0.8323 Intermediate Similarity NPC118080
0.8323 Intermediate Similarity NPC291599
0.8323 Intermediate Similarity NPC27377
0.8323 Intermediate Similarity NPC97947
0.8323 Intermediate Similarity NPC87448
0.8323 Intermediate Similarity NPC41481
0.8323 Intermediate Similarity NPC16912
0.8313 Intermediate Similarity NPC472398
0.8303 Intermediate Similarity NPC165234
0.8303 Intermediate Similarity NPC475536
0.8295 Intermediate Similarity NPC33372
0.8295 Intermediate Similarity NPC67246
0.8294 Intermediate Similarity NPC470580
0.8291 Intermediate Similarity NPC20255
0.8282 Intermediate Similarity NPC477470
0.8282 Intermediate Similarity NPC477474
0.8282 Intermediate Similarity NPC477472
0.828 Intermediate Similarity NPC475122
0.828 Intermediate Similarity NPC472569
0.828 Intermediate Similarity NPC472573
0.828 Intermediate Similarity NPC476974
0.828 Intermediate Similarity NPC472570
0.828 Intermediate Similarity NPC470152
0.828 Intermediate Similarity NPC11685

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471493 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8855 High Similarity NPD8368 Discontinued
0.8698 High Similarity NPD8407 Phase 2
0.8675 High Similarity NPD8470 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD8360 Approved
0.8497 Intermediate Similarity NPD8361 Approved
0.8497 Intermediate Similarity NPD8435 Approved
0.8393 Intermediate Similarity NPD7799 Discontinued
0.8278 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD8434 Phase 2
0.8171 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.8111 Intermediate Similarity NPD8485 Approved
0.7989 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD7236 Approved
0.7758 Intermediate Similarity NPD7239 Suspended
0.7756 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD8150 Discontinued
0.7611 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD8462 Phase 1
0.7526 Intermediate Similarity NPD8320 Phase 1
0.7526 Intermediate Similarity NPD8319 Approved
0.7514 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7487 Intermediate Similarity NPD7699 Phase 2
0.7487 Intermediate Similarity NPD7700 Phase 2
0.7474 Intermediate Similarity NPD7435 Discontinued
0.7444 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD6534 Approved
0.7419 Intermediate Similarity NPD6535 Approved
0.7403 Intermediate Similarity NPD8312 Approved
0.7403 Intermediate Similarity NPD8313 Approved
0.7374 Intermediate Similarity NPD8404 Phase 2
0.7348 Intermediate Similarity NPD7808 Phase 3
0.7341 Intermediate Similarity NPD7058 Phase 2
0.7341 Intermediate Similarity NPD7057 Phase 3
0.7333 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7874 Approved
0.7299 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7075 Discontinued
0.7293 Intermediate Similarity NPD7251 Discontinued
0.7263 Intermediate Similarity NPD3751 Discontinued
0.7238 Intermediate Similarity NPD6797 Phase 2
0.7233 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6781 Approved
0.7225 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6776 Approved
0.7225 Intermediate Similarity NPD6778 Approved
0.7225 Intermediate Similarity NPD6779 Approved
0.7225 Intermediate Similarity NPD6782 Approved
0.7225 Intermediate Similarity NPD6777 Approved
0.7225 Intermediate Similarity NPD6780 Approved
0.7204 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7697 Approved
0.7202 Intermediate Similarity NPD7696 Phase 3
0.7202 Intermediate Similarity NPD7698 Approved
0.7198 Intermediate Similarity NPD7685 Pre-registration
0.7186 Intermediate Similarity NPD6190 Approved
0.7182 Intermediate Similarity NPD7074 Phase 3
0.7165 Intermediate Similarity NPD7871 Phase 2
0.7165 Intermediate Similarity NPD7870 Phase 2
0.716 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7701 Phase 2
0.7127 Intermediate Similarity NPD7054 Approved
0.7121 Intermediate Similarity NPD7801 Approved
0.7093 Intermediate Similarity NPD7458 Discontinued
0.7088 Intermediate Similarity NPD7472 Approved
0.7086 Intermediate Similarity NPD5402 Approved
0.7072 Intermediate Similarity NPD3818 Discontinued
0.7069 Intermediate Similarity NPD6801 Discontinued
0.7052 Intermediate Similarity NPD4380 Phase 2
0.7052 Intermediate Similarity NPD6599 Discontinued
0.7039 Intermediate Similarity NPD3787 Discontinued
0.7029 Intermediate Similarity NPD7819 Suspended
0.7024 Intermediate Similarity NPD4628 Phase 3
0.7011 Intermediate Similarity NPD6559 Discontinued
0.6978 Remote Similarity NPD7228 Approved
0.6976 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6974 Remote Similarity NPD2629 Approved
0.6946 Remote Similarity NPD7266 Discontinued
0.694 Remote Similarity NPD5844 Phase 1
0.6935 Remote Similarity NPD8151 Discontinued
0.6933 Remote Similarity NPD7961 Discontinued
0.6923 Remote Similarity NPD8166 Discontinued
0.6923 Remote Similarity NPD7473 Discontinued
0.6911 Remote Similarity NPD6213 Phase 3
0.6911 Remote Similarity NPD6212 Phase 3
0.6911 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6893 Remote Similarity NPD3817 Phase 2
0.6888 Remote Similarity NPD6823 Phase 2
0.6879 Remote Similarity NPD5403 Approved
0.6879 Remote Similarity NPD8328 Phase 3
0.6875 Remote Similarity NPD37 Approved
0.6872 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6869 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6868 Remote Similarity NPD6166 Phase 2
0.6868 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6868 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6865 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6854 Remote Similarity NPD4967 Phase 2
0.6854 Remote Similarity NPD4966 Approved
0.6854 Remote Similarity NPD4965 Approved
0.6854 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6836 Remote Similarity NPD8455 Phase 2
0.6818 Remote Similarity NPD4198 Discontinued
0.6802 Remote Similarity NPD6799 Approved
0.6798 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7783 Phase 2
0.6778 Remote Similarity NPD6234 Discontinued
0.6763 Remote Similarity NPD5401 Approved
0.6758 Remote Similarity NPD6232 Discontinued
0.6742 Remote Similarity NPD2393 Clinical (unspecified phase)
0.674 Remote Similarity NPD5494 Approved
0.6738 Remote Similarity NPD6765 Approved
0.6738 Remote Similarity NPD6764 Approved
0.6738 Remote Similarity NPD7240 Approved
0.6723 Remote Similarity NPD7411 Suspended
0.6709 Remote Similarity NPD5125 Phase 3
0.6709 Remote Similarity NPD5126 Approved
0.6707 Remote Similarity NPD7008 Discontinued
0.6703 Remote Similarity NPD8127 Discontinued
0.6685 Remote Similarity NPD1934 Approved
0.6667 Remote Similarity NPD3882 Suspended
0.6667 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6648 Remote Similarity NPD5761 Phase 2
0.6648 Remote Similarity NPD5760 Phase 2
0.6646 Remote Similarity NPD8513 Phase 3
0.6646 Remote Similarity NPD8515 Approved
0.6646 Remote Similarity NPD8516 Approved
0.6646 Remote Similarity NPD8517 Approved
0.663 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6628 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6626 Remote Similarity NPD6007 Clinical (unspecified phase)
0.661 Remote Similarity NPD3226 Approved
0.6605 Remote Similarity NPD7736 Approved
0.6604 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6603 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6597 Remote Similarity NPD6785 Approved
0.6597 Remote Similarity NPD6784 Approved
0.6595 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6591 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6582 Remote Similarity NPD7741 Discontinued
0.6571 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6571 Remote Similarity NPD2532 Approved
0.6571 Remote Similarity NPD2534 Approved
0.6571 Remote Similarity NPD2533 Approved
0.6571 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6564 Remote Similarity NPD7319 Approved
0.6556 Remote Similarity NPD2801 Approved
0.6552 Remote Similarity NPD3300 Phase 2
0.655 Remote Similarity NPD7702 Clinical (unspecified phase)
0.655 Remote Similarity NPD2346 Discontinued
0.6548 Remote Similarity NPD230 Phase 1
0.6538 Remote Similarity NPD690 Clinical (unspecified phase)
0.6532 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6529 Remote Similarity NPD7305 Phase 1
0.6522 Remote Similarity NPD6959 Discontinued
0.6522 Remote Similarity NPD7199 Phase 2
0.6517 Remote Similarity NPD7497 Discontinued
0.6514 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6513 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6484 Remote Similarity NPD7768 Phase 2
0.6477 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6474 Remote Similarity NPD6010 Discontinued
0.6474 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6471 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6467 Remote Similarity NPD3764 Approved
0.6465 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6464 Remote Similarity NPD1465 Phase 2
0.6448 Remote Similarity NPD3749 Approved
0.6442 Remote Similarity NPD7930 Approved
0.6441 Remote Similarity NPD6273 Approved
0.6437 Remote Similarity NPD3750 Approved
0.6433 Remote Similarity NPD5951 Approved
0.6425 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6425 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6422 Remote Similarity NPD7584 Approved
0.6419 Remote Similarity NPD8058 Clinical (unspecified phase)
0.6419 Remote Similarity NPD8059 Phase 3
0.6416 Remote Similarity NPD970 Clinical (unspecified phase)
0.6416 Remote Similarity NPD1549 Phase 2
0.6415 Remote Similarity NPD7907 Approved
0.64 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6398 Remote Similarity NPD6370 Approved
0.6398 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6395 Remote Similarity NPD6100 Approved
0.6395 Remote Similarity NPD6099 Approved
0.6395 Remote Similarity NPD2935 Discontinued
0.6389 Remote Similarity NPD7028 Phase 2
0.6387 Remote Similarity NPD5030 Phase 2
0.6387 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6387 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6384 Remote Similarity NPD7422 Clinical (unspecified phase)
0.638 Remote Similarity NPD7507 Approved
0.6379 Remote Similarity NPD6674 Discontinued
0.6374 Remote Similarity NPD7097 Phase 1
0.6373 Remote Similarity NPD7999 Approved
0.6369 Remote Similarity NPD1653 Approved
0.6364 Remote Similarity NPD2182 Approved
0.6358 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6358 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6358 Remote Similarity NPD1552 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data